Notizie Estrella Immunopharma - ESLAW

Ultime notizie

Data	Ora	Fonte	Titolo
21/2/2025	14:30	EDGAR2	Form 8-K - Current report
21/2/2025	14:30	BW	Estrella Immunopharma Completes First Dose Cohort in..
19/2/2025	22:46	BW	Estrella Immunopharma, Inc. (NASDAQ: ESLA; ESLAW) Receives..
14/2/2025	22:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
14/2/2025	22:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
23/12/2024	20:43	EDGAR2	Form S-8 - Securities to be offered to employees in employee..
20/12/2024	06:15	EDGAR2	Form EFFECT - Notice of Effectiveness
17/12/2024	22:59	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
16/12/2024	22:00	EDGAR2	Form 8-K - Current report
12/12/2024	23:08	EDGAR2	Form S-3 - Registration statement under Securities Act of..
09/12/2024	20:45	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
06/12/2024	15:12	EDGAR2	Form 8-K - Current report
27/11/2024	14:45	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
26/11/2024	23:00	EDGAR2	Form 8-K - Current report
25/11/2024	22:00	EDGAR2	Form 8-K - Current report
18/11/2024	23:18	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
14/11/2024	22:15	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/2024	23:27	EDGAR2	Form 8-K/A - Current report: [Amend]
07/11/2024	23:26	EDGAR2	Form 8-K - Current report
28/10/2024	22:03	EDGAR2	Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
02/10/2024	23:19	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
27/9/2024	18:00	BW	Estrella Immunopharma Achieves Complete Response in First..
14/8/2024	18:00	BW	Estrella Immunopharma Announces Appointment of Hong Zhang as..

Apertura: 0,0939	Min: 0,06	Max: 0,0955
Chiusura: 0,08495